Over 10 years relative median survival in MM patients ≤ 65 years with VGPR or better on 1st line treatment. Population-based data on patients diagnosed 2008-2018 from the Swedish Myeloma Registry

被引：0

作者：

Blimark, Cecilie Hveding ^{[1
]}

Genell, Anna ^{[2
]}

Lund, Johan ^{[3
]}

Nahi, Hareth ^{[4
]}

Carlson, Kristina ^{[5
]}

Forsberg, Karin ^{[6
]}

Juliusson, Gunnar ^{[7
]}

Lauri, Birgitta ^{[8
]}

Linder, Olle ^{[9
]}

Danielsson, Signe ^{[9
]}

Svensson, Ronald ^{[10
]}

Vesskovski, Ljupco ^{[11
]}

Knut-Bojanowska, Dorota ^{[12
]}

Turesson, Ingemar ^{[13
]}

机构：

[1] Sahlgrens Univ Hosp, Gothenburg, Vastra Gotaland, Sweden

[2] Reg Canc Ctr, Gothenburg, AS, Sweden

[3] Karolinska Inst, Dept Hematol, Stockholm, Sweden

[4] Karolinska Inst, Stockholm, Sweden

[5] Uppsala Univ Hosp, Dept Hematol 4, Uppsala, Sweden

[6] Umea Univ Hosp, Dept Hematol, Umea, Sweden

[7] Skane Univ Hosp, Hematol Transplantat Stem Cell Ctr, Lund, Sweden

[8] Sunderby Hosp, Lulea, Sweden

[9] Orebro Univ Hosp, Dept Hematol, Orebro, Sweden

[10] Linkoping Univ Hosp, Dept Hematol, Linkoping, Sweden

[11] Boras Hosp, Dept Hematol, Boras, Sweden

[12] Uddevalla Sjukhus, Uddevalla, Sweden

[13] Skane Univ Hosp, Dept Hematol, Malmo, Sweden

来源：

关键词：

registry; survival; VGPR;

D O I：

10.1016/j.clml.2019.09.347

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

SP-021

引用

页码：E209 / E209

页数：1